Clinical Trial Update: Pregnenolone Sulfate an Early Marker of the Memory Loss in Alzheimer's Disease

View source ↗

Summary

A completed clinical trial update suggests pregnenolone sulfate could serve as an early biomarker for memory loss in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Pregnenolone sulfate (pregnenolone sulfate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Alzheimer Disease | Status: COMPLETED